Leading Cancer Organizations Warn Cancer Doesn’t Stop for COVID-19 and Neither Should You

The National Comprehensive Cancer Network (NCCN) and the American Cancer Society (ACS) are teaming up with leading cancer organizations across the country to endorse prioritizing the safe resumption of cancer screening and treatment during the ongoing COVID-19 pandemic. The coalition of 76 organizations is releasing an open letter about the threat cancer still poses to people’s health and a reminder that acting as soon as is safely possible can lead to much better outcomes in the future.

Brooke Emerling awarded Research Scholar Grant by American Cancer Society

Sanford Burnham Prebys Medical Discovery Institute is pleased to announce that the American Cancer Society has awarded Brooke Emerling, Ph.D., a Research Scholar Grant (RSG) to study a new approach to targeting tumors that have a mutation in the p53 gene—the most altered gene in human cancers. The grants are often a career-launching award for “rising stars” in the cancer research arena. The four-year grant will help advance Emerling’s research toward eliminating cancer as a major health problem.

Younger Cancer Survivors Far More Likely to Experience Food and Financial Insecurity than their Cancer-Free Peers, According to Researchers from American Cancer Society

New research from the American Cancer Society in the March 2020 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds that younger cancer survivors are more likely to experience significant financial strain for food, housing, and monthly bills after diagnosis.

Opioid Self-management Practices and Potential Safety Risks Among Patients with Cancer

Despite a national opioid crisis, prescribed opioid analgesics remain a viable option for pain management for patients with cancer. In effect, patients with cancer represent one of the few groups excluded from most state legislation and policy initiatives on prescribing opioids as well as from opioid stewardship programs of many health systems. However, little is understood about oncology patients’ opioid self-management practices and potential safety risk that may stem from these practices.

Bonni Lee Guerin, MD Honored By American Cancer Society – Northeast Region

Bonni Lee Guerin, MD, hematologist/oncologist and physician researcher at Overlook Medical Center, was honored by the American Cancer Society for her role in advancing breast cancer treatment and prevention. In addition to her forward-looking clinical approach, Dr. Guerin is the principal investigator (PI) of numerous clinical trials exploring new ways to incorporate the latest advances in the management of breast cancer. Dr. Guerin was PI at Atlantic Health System, with the largest number of study participants of any center in the New York-New Jersey metro area, for the landmark TAILORx clinical trial.

Intestinal Stem Cell Genes May Link Dietary Fat and Colon Cancer

Two genes that appear to help stem cells in the intestine burn dietary fat may play a role in colon cancer, according to a Rutgers study. The study, published in the journal Gastroenterology, describes a new connection between the way cells consume fat and how genes regulate stem cell behavior in the intestines of mice.

Pioneering oncology researcher leads publication of new exercise prescriptions for cancer prevention, survival

Oncology nurse practitioner Anna Schwartz, a professor at Northern Arizona University, was a leader on the team that reviewed the latest scientific evidence and offered recommendations about the benefits of exercise for prevention, treatment, recovery and improved survival, which were shared this week in three publications.